Sentiment Trading

SelectQuote Inc. reports mixed Q3 2025 results, with 41% growth in SelectRx membership, but a cautious outlook and financial challenges, including a negative P/E ratio, raise concerns about the company’s future prospects.

SelectQuote Inc. is facing legal challenges and a decline in stock value due to allegations of Medicare kickbacks and a False Claims Act complaint filed by the US Department of Justice.